the future of aml and mds diagnosis and treatment
Published 7 years ago • 322 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:02
bispecific agents: the future of aml and mds treatment?
-
3:37
the future of aml treatment
-
1:35
challenges with diagnosing mds and future outlooks
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:50
phase ii study of vibecotamab in mrd aml and mds & cmml after hma failure
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:43
novel therapies in the future of mds treatment
-
7:46
updates in aml treatment and research from asco 2023
-
6:36
mds: low-risk disease treatment options
-
4:48
managing and treating mds
-
2:16
current and future treatment approaches for hr-mds
-
2:01
the future of menin inhibitors in aml
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:43
reasons why there are fewer treatment options for mds patients and hope for the future
-
1:21
future treatment priorities for high-risk mds
-
1:30
aml & myelodysplasia breakthrough
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:04
the future of mds management
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
2:04
state-of-the-art treatment for hr-mds